Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2020 08:00 ET | Source: Mateon Therapeutics, Inc.

MATEON AND GMP COMPLETED RESEARCH AND SERVICE AGREEMENT

- Mateon and GMP to proceed to clinical development of OT-101 and Artemisin and other antisense drug candidates against COVID-19 AGOURA HILLS, Calif., June 22, 2020 (GLOBE NEWSWIRE) --...